To outline current techniques in robotic cardiac surgery and to report the recent results.
Introduction
Robotic surgery is the natural progression in the evolution of cardiac surgery. Outstanding, durable results have been achieved by traditional open surgical approaches. Further procedural development dictated the reduction of collateral surgical trauma while maintaining excellent longlasting results. Minimally invasive techniques were first introduced to cardiac surgery in the mid-1990s with modified cardiopulmonary bypass (CPB) methods, limited incisions. Procedures were first performed with long shafted instruments under direct vision [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] , and evolved to include either partial or total two-dimensional videoscopic guidance [16] [17] [18] [19] [20] [21] [22] . The da Vinci Surgical System (Intuitive Surgical Inc., Sunnyvale, California, USA) has overcome many of the limitations of long-shafted instruments by incorporating three-dimensional visualization with articulating wrist instrumentation, providing 7 degrees of freedom and making delicate intracorporeal surgery possible within confined spaces. The latest system, da Vinci Si, provides three-dimensional visioning in 1080i high definition with up to 10Â magnification. A dual console system ( Fig. 1 ) with push-button instrument exchange facilitates assistance and teaching allowing sur-geon and assistant to work together as pilot and co-pilot [23] . On the basis of the success of robotic mitral surgery, surgical telemanipulation has expanded to other cardiac procedures, including coronary revascularization, arrhythmia operations, left ventricular lead implantation, congenital heart surgery, and aortic valve replacement.
Anesthetic considerations
Some modifications of anesthetic principles for open cardiac surgery are key to ensure the success and safety of robotic cases. Often, a 17 French right internal jugular venous cannula is used to augment venous drainage. In certain cases, the anesthesiologist also secures a pulmonary artery vent and coronary sinus cardioplegia catheter. If an endoaortic occlusion device is used, bilateral radial arterial catheters are required to monitor correct balloon placement. We also utilize bispectral analysis to monitor depth of anesthesia to assist in fast-tracking patients, aiming for a target of less than 60. Near-infrared spectral analysis aids in ensuring adequate brain protection and leg perfusion [24] with alternative cannulation strategies. Defibrillator pads are required, as internal paddles cannot be applied through limited incisions.
Single-lung ventilation is preferred for robotic cardiac surgery, but may reduce cardiac output and result in hypoxia and hypercapnia, thereby increasing pulmonary artery resistance. During total endoscopic coronary artery bypass grafting (TECAB), carbon dioxide insufflation is required, which may exacerbate hypercapnia and impede venous return and cardiac filling.
We now rely almost exclusively on high-quality intraoperative 3D Transesophageal echocardiographic (TEE) imaging to plan mitral valve repair. Each valve segment is measured as well as the mitral valve-aortic annular plane, the C-septal distance, and thickness of interventricular septum to minimize the potential for systolic anterior motion (SAM) of the anterior mitral valve leaflet. The 3DTEE topographic model is used to plan the operation and size the annuloplasty band. A saline test is performed intraoperatively to confirm the echocardiographic findings, but only occasionally do we still measure the valve segments directly.
Vascular access and perfusion techniques
Cardiopulmonary bypass is most commonly achieved by femoral arterial and venous cannulation. Thin-wall cannulas are positioned using a modified Seldinger guidewire technique under TEE guidance. Transthoracic aortic or axillary artery [25 ] cannulation may be more appropriate for patients with peripheral atherosclerosis. Vascular injuries from femoral cannulation include arterial occlusion, localized arterial injuries, and aortic dissections. Major aortic dissection is rare, but devastating, and occurs in 1-2% of patients [26] [27] [28] [29] . To avoid these complications, preoperative screening for peripheral vascular disease may include noninvasive plethsmography, computed tomography, or selective angiography. 78 
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Key points
Early results of robotic cardiac surgical procedures are encouraging with evidence demonstrating fewer blood transfusions, shorter hospital stay, faster return to preoperative function levels, and improved quality of life compared with those having a sternotomy. Robotic mitral valve repair and total endoscopic coronary artery bypass surgery have become standardized procedures at specialized centers. Success of a robotic program is highly dependent on the skill sets, experience, and dedication of the entire team.
Stepwise progression of robotic technology and procedure development will continue to make robotic operations simpler and more efficient. Aortic occlusion methods include the transthoracic aortic cross-clamp and endoaortic balloon occlusion. The clamping method has achieved standardization in most minimally invasive cardiac surgery centers worldwide. The transthoracic Chitwood clamp (Scanlan International, Minneapolis, Minnesota, USA) is applied across the aorta in the transverse sinus, taking care not to injure the pulmonary artery or the left atrial appendage [30] . We have had no aortic injuries from the transthoracic clamp in over 1000 minimally invasive cases. Alternatively, some surgeons prefer an endoaortic occlusion balloon, which is advanced through the side arm of the femoral arterial perfusion catheter and positioned 1 cm above the sinotubular junction under TEE guidance. Reichenspurner et al. [31] demonstrated increased morbidity, total operative and cross-clamp times, and cost for the endoaortic balloon versus the transthoracic clamp. Aortic dissection is more common with the endoaortic balloon technique [32] . Hypothermic ventricular fibrillation can be used when aortic access is limited, such as in reoperations.
Mitral valve
Positioning the right arm along the side with gentle elbow flexion has reduced conflict with robotic arms and decreased risks of a brachial plexopathy. A 3-4 cm access incision is made in the right inframammary crease and the chest is entered through the fourth right intercostal space. The pericardium is opened 3-4 cm anterior to the phrenic nerve to prevent transient phrenic nerve traction injuries. After establishing CPB and cardiac arrest, a left atriotomy is made in Sondergaard's groove.
The robotic left atrial retractor allows dynamic exposure of the anterior annulus and both trigones and releasing the left atrial retractor minimizes aortic insufficiency during administration of cardioplegia. Generally, we use conventional mitral valve repair techniques, including posterior leaflet resections, sliding plasties, chordal transfers, and neochordal placement. However, our focus has been on limited resections and leaflet conservation using methods that reduce posterior leaflet width and still provide leaflet-annular continuity. Robotic visualization is particularly advantageous when working deep within the left ventricle as during neochordal replacements or papillary muscle reconstructions. Repairs are supported with an annuloplasty band or ring. A temporary right ventricular pacing wire should be placed robotically before the transthoracic aortic cross-clamp is removed. At this point, the robotic arms are removed and the patient weaned from CPB. After hemodynamic stabilization, TEE is performed to assess repair quality and left ventricular function.
Endoscopic mitral valve repairs were first performed using a prototype of the da Vinci Surgical System in May 1998 [33, 34] . In May 2000, our group performed the first complete da Vinci mitral repair in North America [35] and subsequently participated in the phase I [36] and phase II [26] US Food and Drug Administration (FDA) trials. Our own experience now includes over 540 patients from May 2000 to April 2010. Postrepair echocardiograms showed 527 (97.6%) with none or trace of mitral regurgitation. We have reported echocardiographic and survival follow-up in 93 and 100% of the first 300 patients, respectively [37 ] . There were two (0.7%) 30 Robotic mitral valve repair has been criticized for increased cross-clamp and operative times. The introduction of newer robotic instrumentation such as the dynamic left atrial retractor [55] and simpler mitral valve repair techniques including the 'haircut posterior leaflet-plasty' [56] , the 'American correction' [57] , premeasured artificial neochordea [42] , and the running annuloplasty suture technique [44 ] have simplified robotic mitral repair and facilitated complex repairs [58] while resulting in shorter operative times and maintaining excellent results.
Coronary revascularization
The patient is placed in a 308 right lateral decubitus position. For arrested heart TECAB (AH TECAB), the left femoral artery and vein are cannulated and the endoballoon is positioned under echocardiographic guidance in the ascending aorta. For patients in whom use of an endoaortic occlusion balloon is contraindicated due to aorto/iliac calcification, tortuosity, or aneurysmal disease, beating heart TECAB (BH TECAB) can be considered.
In BH TECAB cases, we recommend prophylactic axillary arterial and percutaneous venous cannulation and instituting CPB only if required. This strategy provides a safety net while minimizing the risk of stroke [25 ] . Instrument ports are placed in the third, fifth, and seventh intercostal spaces. A 7 mm assistant port is sometimes used in the fourth left intercostal space and a robotic stabilizer can be secured through a left subcostal port for BH TECAB or to position the heart for (continued overleaf ) multivessel AH TECAB. Carbon dioxide is insufflated to approximately 10 mmHg to increase working space and enhance visualization of the operative field. The pericardial fat pad is excised and the pericardium opened. For AH TECAB, CPB is instituted and the heart arrested with antegrade blood cardioplegia. Target vessels are identified and the anastomosis is completed with suture, U clips or an anastomotic connector device. Graft patency is assessed using transit-time flow measurements. The endoballoon is deflated and when a stable rhythm is established, the patient is weaned from CPB [59] .
The scope of robot-assisted coronary operations ranges from internal mammary artery (IMA) harvest with a handsewn anastomosis, performed on pump through a median sternotomy, to multivessel off-pump TECAB. Early reports demonstrated the feasibility and safety of harvesting the IMA with the da Vinci system with harvest times less than 30 min achievable once the learning curve had been negotiated [60] [61] [62] .
In 1998, Loulmet et al. [63] were the first to report a completely endoscopic left internal mammary artery (LIMA) left anterior descending artery (LAD) coronary bypass procedure. Since then, advances in technology and surgical techniques have facilitated the progression from single-vessel LIMA to LAD to quadruple-vessel bypass in BH TECAB and triple-vessel bypass in AH arrested heart TECAB [53 ,54 ] . Multivessel revascularization graft configurations can include combi-nations of single, sequential, T, or Y grafts, generally based on one or both IMAs. Radial artery and saphenous vein has also been used to construct composite grafts.
Owing to the difficulty in constructing proximal aortocoronary graft anastomoses endoscopically from the left, and to increase the range of potential target vessels, we recently introduced axillary coronary bypass using saphenous vein [64] . The success of robotic IMA grafting has led to its inclusion in hybrid (single IMA to LAD and percutaneous intervention of one or two additional target vessels) and advanced hybrid (double IMA grafting with percutaneous intervention of one or more additional target vessels; Fig. 2 ) procedures [65 ,59,60] .
Major robotic revascularization trials are summarized in Table 1 (part 2) [46-52,53 ,54 ] . In 771 published cases, there have been no mortalities and a 0.7% rate of stoke. Operative times are long in the early phases of program development, but as teams move along learning curves, single-vessel TECAB can be performed in less than 2 h. Overall freedom from major cardiac and cerebral events, and angina are within the ranges of published studies of traditional coronary artery bypass grafting. Compared with sternotomy, patients undergoing TECAB can expect improved physical health, a shorter hospital stay, and sooner return to their daily activities [66 ] . Irrespective of the method, long-term follow-up of these grafts is needed to determine whether they maintain the same excellent patency (>90% at 10 years) as those performed through a median sternotomy. 
Atrial fibrillation surgery
Full Cox-Maze III right and left lesion sets can be made with robotic assistance, which significantly enhances visualization of the lesions to minimize the risk of gaps, which may result in failures. Generally, we perform the right-sided lesions on CPB. The left-sided lesions are performed after opening the left atrium. We previously published our cryolesion set [67] .
There have been a few case reports of patients undergoing combined robotic mitral valve and atrial fibrillation surgery demonstrating that these procedures are well tolerated [68] [69] [70] [71] . One small (n ¼ 16) series of patients undergoing combined robotic mitral valve and atrial fibrillation surgery using the Flex-10 microwave catheter (Guidant, Indianapolis, Indiana, USA) from our own institution has been reported [72] . The ablative procedure added 42 AE 16 min to the mitral valve repair and 1.3 days to hospitalization. At 6-month follow-up, 73% were in sinus rhythm, 20% were paced, and 7% were in atrial fibrillation. Cheema et al. [73] recently reported their robotic endoscopic Cox-Cryomaze technique. Using a warm beating heart strategy, they were able to perform a full set of left atrial argon-based cryolesions and closure of the left atrial appendage.
Other procedures
A number of other cardiac procedures have been described and are in various stages of development. The patient underwent a staged hybrid coronary revascularization procedure consisting of robotically assisted total endoscopic coronary artery bypass grafting of the right internal mammary artery to the left anterior descending artery (a) and the left internal mammary artery to the first diagonal branch (b). Under dual arterial graft protection of the left anterior descending arterial territory, a bare metal stent was successfully placed across the left main coronary artery bifurcation into the circumflex coronary artery (c and d) on postoperative day 5.
Left ventricular epicardial lead placement
Percutaneous left ventricular lead placement via the coronary sinus cannulation is associated with long fluoroscopy times and is limited by coronary venous anatomy [74] . The robotic approach is an attractive alternative to the percutaneous technique, as it allows surgeons to determine the best epicardial site for implantation by mapped stimulation allowing greater success rates than transvenous implantation. No complications or technical failures were reported in two series comprising 54 patients [75, 76] .
Intracardiac tumor resection
Intracardiac tumors should generally be resected to prevent thromboembolic complications. A small case series describes the endoscopic excision of left atrial myxomas using either a left atriotomy or a right atriotomy with a trans-septal approach. Autologous pericardial patches were used to repair septal defects following excision. Impressive results were reported, with all patients being discharged on day 4 and resuming normal activity 3 weeks after surgery [77] . Subsequently, a series of 19 consecutive patients with atrial myxoma undergoing robotic excision on the beating heart was reported. Resection was achieved in all 19 patients without surgical mortality or stroke. Follow-up echocardiograms up to 18 months noted no recurrence or atrial septal defect [78 ] . Successful excision of an aortic valve papillary fibroelastoma has also been described [79] .
Congenital surgery
Patent ductus arteriosus closure and vascular ring repair have been successfully completed robotically [80] , however, widespread application of robotic technology in pediatric congenital cardiac surgery has been limited. On the other hand, Atrial septal defect (ASD) closure in adult patients has been more widely described. A FDA trial demonstrated that ASDs in adults can be closed safely and effectively using totally endoscopic robotic approaches [81] . Subsequently, it was demonstrated that robotic ASD closure hastens postoperative recovery and improves quality of life compared with either a minithoracotomy or median sternotomy approach [82] . Robotic ASD closure can be performed on the arrested heart [83] or on the beating heart with CPB [84] . The learning curve is steep, but is associated with a rapid decrease in operative times [85] . Feasibility of total endoscopic robotic ventricular septal defect repair was recently reported in a small case series [86 ] .
Aortic valve surgery
Experience with robotic aortic valve surgery is limited to a small number of case reports with only a portion of the procedure performed robotically [87] . Last year, the firstin-human robot-assisted endoscopic aortic valve replacement was performed.
Conclusion
Although robotic cardiac surgery is in a state of evolution, the early results are encouraging, with evidence demonstrating fewer blood transfusions, shorter hospital stay, faster return to preoperative function levels, and improved quality of life compared with those having a sternotomy. These outcomes translate into improved utilization of limited healthcare resources. It is clear that the continued evolution of totally endoscopic cardiac surgery depends on the further development of new robotic platforms and adjunctive technology, such as retraction systems, perfusion catheters, and sutureless anastomotic devices. Surgical scientists must continue to combine efforts with our industry partners to advance this technology and critically evaluate it. Traditional cardiac operations still enjoy proven long-term success and ever-decreasing morbidity and mortality, and remain the standard to which outcomes will be measured. Long-term results are needed to determine whether robotic techniques could become the new standard in cardiac surgery. Stepwise progression of robotic technology and procedure development will continue to make robotic operations simpler and more efficient, which will encourage more surgeons to take up this technology and extend the benefits of robotic surgery to a larger patient population.
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